AUTHOREA
Log in Sign Up Browse Preprints

loading page

Management Considerations of Hodgkin Lymphoma for Patients with Fontan Physiology
  • Michelle Perry Milligan,
  • Leslie Kersun
Michelle Perry Milligan
The Children's Hospital of Philadelphia

Corresponding Author:perrymillm@chop.edu

Author Profile
Leslie Kersun
The Children's Hospital of Philadelphia
Author Profile

Abstract

While treatment protocols for Hodgkin Lymphoma (HL) are well established, there is no literature available to guide therapy or estimate prognosis for patients with Fontan physiology who develop HL. The physiology of a Fontan procedure can result in the inability to tolerate chemotherapy toxicities, supportive care and infection. We present a series of 3 patients with Fontan physiology who were treated for HL and discuss their clinical course and treatment.

Peer review status:Published

15 Nov 2021Submission Checks Completed
Show details
Hide details
15 Nov 2021Assigned to Editor
15 Nov 2021Submitted to Pediatric Blood & Cancer
18 Nov 2021Reviewer(s) Assigned
05 Dec 2021Review(s) Completed, Editorial Evaluation Pending
16 Dec 2021Editorial Decision: Revise Minor
21 Dec 2021Submission Checks Completed
21 Dec 2021Assigned to Editor
21 Dec 20211st Revision Received
23 Dec 2021Reviewer(s) Assigned
11 Jan 2022Review(s) Completed, Editorial Evaluation Pending
13 Jan 2022Editorial Decision: Accept
Apr 2022Published in Pediatric Blood & Cancer volume 69 issue 4. 10.1002/pbc.29587